Search Results - "Krackhardt, A"

Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany by Bailey, D. L., Pichler, B. J., Gückel, B., Antoch, G., Barthel, H., Bhujwalla, Z. M., Biskup, S., Biswal, S., Bitzer, M., Boellaard, R., Braren, R. F., Brendle, C., Brindle, K., Chiti, A., la Fougère, C., Gillies, R., Goh, V., Goyen, M., Hacker, M., Heukamp, L., Knudsen, G. M., Krackhardt, A. M., Law, I., Morris, J. C., Nikolaou, K., Nuyts, J., Ordonez, A. A., Pantel, K., Quick, H. H., Riklund, K., Sabri, O., Sattler, B., Troost, E. G. C., Zaiss, M., Zender, L., Beyer, Thomas

“…The 6th annual meeting to address key issues in positron emission tomography (PET)/magnetic resonance imaging (MRI) was held again in Tübingen, Germany, from…”
Get full text

Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV by Wisskirchen, K, Kah, J, Metzger, K, Weigand, L, Uckert, W, Schiemann, M, Volz, T, Krackhardt, A, Dandri, M, Protzer, U

Get full text

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells by Klar, R, Schober, S, Rami, M, Mall, S, Merl, J, Hauck, S M, Ueffing, M, Admon, A, Slotta-Huspenina, J, Schwaiger, M, Stevanović, S, Oostendorp, R A J, Busch, D H, Peschel, C, Krackhardt, A M

“…T cells have been proven to be therapeutically effective in patients with relapsed leukemias, although target antigens on leukemic cells as well as T-cell…”
Get full text

Transgenic antigen-specific, HLA-A02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+ tumour cells in vivo by Schirmer, D, Grünewald, T, Klar, R, Schmidt, O, Wohlleber, D, Alba Rubío, R, Uckert, W, Thiel, U, Protzer, U, Busch, D, Krackhardt, A, Burdach, S, Richter, G

“…Background: Paediatric cancers, including Ewing sarcoma (ES), are only weakly immunogenic and the tumour-patients immune system often is devoid of effector T…”
Get full text

Selective Depletion of Alloreactive T-cells While Retaining Virus-specific and Memory T-cells from Haploidentical Donor Lymphocytes by van der Hoorn, M, Geraedts, M, Krackhardt, A, Maertens, J, Walker, I, Bönig, H, Roy, D, Velthuis, J, Ruediger, M

Get full text

Leukemia-associated Antigen Reactive T-cells in ATIR101, a Recipient-specific Allodepleted T-cell Product to Reduce Relapse Rates and GVHD after Haplo-HSCT by Velthuis, J, Klar, R, Bönig, H, Rovers, J, Roy, D, Prokop, L, Stevanovic, S, Ruediger, M, Krackhardt, A

Get full text

Functional Characterization of HBV-Specific T Cell Receptors for Redirection of T Cells Against HBV-Infected Hepatocytes by Wisskirchen, K, Metzger, K, Weigand, L, Kieback, E, Sprinzl, M, Uckert, W, Busch, D.H, Krackhardt, A, Protzer, U

Get full text

P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias by Richard, K, Schober, S, Rami, M, Mall, S, Merl, J, Slotta-Huspenina, J, Stevanovic, S, Busch, DH, Peschel, C, Krackhardt, AM

“…BackgroundT cells have proven to be effective for the treatment of leukaemias in form of donor lymphocyte infusions (DLI). However, those DLI are of unknown…”
Get full text

Induction of cytotoxic T-cell responses against immunoglobulin V region–derived peptides modified at human leukocyte antigen–A2 binding residues by Harig, Sabine, Witzens, Mathias, Krackhardt, Angela M., Trojan, Andreas, Barrett, Patrick, Broderick, Ryan, Zauls, A. Jason, Gribben, John G.

“…Cytotoxic T-lymphocyte (CTL) responses can be generated against peptides derived from the immunoglobulin (Ig) V region in some but not all patients. The main…”
Get full text

Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule by TROJAN, Andreas, WITZENS, Mathias, SCHULTZE, Joachim L, VONDERHEIDE, Robert H, HARIG, Sabine, KRACKHARDT, Angela M, STAHEL, Rolf A, GRIBBEN, John G

“…A growing number of human tumor antigens have been described that can be recognized by CTLs in a MHC class I restricted fashion. The epithelial cell adhesion…”
Get full text

PS-031 - T cells grafted with HBV-specific T-cell receptors of high functional avidity achieve functional cure of HBV infection in humanized mice by Wisskirchen, K., Kah, J., Malo, A., Allweiss, L., Metzger, K., Volz, T., Krackhardt, A., Dandri-Petersen, M., Protzer, U.

Get full text

T cells grafted with HBV-specific T-cell receptors of high functional avidity achieve functional cure of HBV infection in humanized mice by Wisskirchen, K., Kah, J., Malo, A., Allweiss, L., Metzger, K., Volz, T., Krackhardt, A., Dandri-Petersen, M., Protzer, U.

Get full text

Activation of autologous lymphocytes of patients with chronic myelogenous leukemia in the chronic phase with cytokines and CD3 monoclonal antibody results in bcr/abl- blood leukocyte cultures as determined by reverse transcriptase-polymerase chain reaction by Krackhardt, A, Maurer, J, Thiel, E, Notter, M

“…To investigate the potential of autologous lymphocytes to eliminate chronic myelogenous leukemia (CML) cells following activation and targeting by…”
Get more information

PS-051 - Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBV by Wisskirchen, K., Kah, J., Metzger, K., Weigand, L., Uckert, W., Schiemann, M., Volz, T., Krackhardt, A., Dandri, M., Protzer, U.

Get full text

P09.17 High-resolution of neoantigen-specific T cell receptor activation patterns – moderate stimulation predicts sustained anti-tumor-response by Füchsl, F, Untch, J, Kavaka, V, Jarosch, S, Vogelsang, C, de Andrade Krätzig, N, Gosmann, D, Rad, R, Busch, D, Beltran, E, Bräunlein, E, Krackhardt, A

“…BackgroundNeoantigen-specific T cell receptors (neoTCRs) increasingly receive attention for anti-tumor immunotherapy. Arising from somatic mutations and…”
Get full text

188 - Selective Depletion of Alloreactive T-cells While Retaining Virus-specific and Memory T-cells from Haploidentical Donor Lymphocytes by van der Hoorn, M., Geraedts, M., Krackhardt, A., Maertens, J., Walker, I., Bönig, H., Roy, D., Velthuis, J., Ruediger, M.

Get full text

189 - Leukemia-associated Antigen Reactive T-cells in ATIR101, a Recipient-specific Allodepleted T-cell Product to Reduce Relapse Rates and GVHD after Haplo-HSCT by Velthuis, J., Klar, R., Bönig, H., Rovers, J., Roy, D., Prokop, L., Stevanovic, S., Ruediger, M., Krackhardt, A.

Get full text

27 - Functional Characterization of HBV-Specific T Cell Receptors for Redirection of T Cells Against HBV-Infected Hepatocytes by Wisskirchen, K., Metzger, K., Weigand, L., Kieback, E., Sprinzl, M., Uckert, W., Busch, D.H., Krackhardt, A., Protzer, U.

Get full text

P70. Development of clinically implementable imaging strategies for tracking T cell receptor-transgenic T cells by Mall, S, D'Alessandria, C, Aichler, M, Walch, A, Essler, M, Schwaiger, M, Peschel, C, Krackhardt, A

“…Transfer of T lymphocytes genetically modified with T-cell receptors (TCR) specific for tumour-associated antigens is a novel therapeutic approach for diverse…”
Get full text

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes by Krebs, K, Metzger, K, Weigand, L, Dargel, C, Kieback, E, Uckert, W, Busch, D, Krackhardt, A, Protzer, U

“…Chronic HBV infection, which is accompanied by a weak and oligoclonal T cell response, is the most common cause of hepatocellular carcinoma (HCC). Current…”
Get full text